Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Lakewood-Amedex Biotherapeutics Inc. (LABT)

NASDAQ

$7.02

$--

(0.00%)

Lakewood-Amedex Biotherapeutics Inc. (LABT) Live Price Chart

Page last updated: 2026-04-27 11:18:00

Key Market Data

Market Cap	$100.25M
Open	$7.09
High	$9.82
Low	$5.75
Previous Close	$7.35
Price Change	--
Percentage Change	0.00%
Volume	16K

Lakewood-Amedex Biotherapeutics Inc. (LABT) Stock Price Today

Lakewood-Amedex Biotherapeutics Inc. (LABT) is currently trading at $7.02 as of 2026-04-27 11:18:00, reflecting a 0.00% move ($-0.00) from the previous close.

In the short term, the stock has returned -18.90% over the past four weeks. Over the last 12 months, Lakewood-Amedex Biotherapeutics Inc. has recorded a -18.90% price change, indicating a Weak performance relative to the broader market.

Lakewood-Amedex Biotherapeutics Inc. (LABT) 7-Day Stock Price Changes

Over the past seven days, Lakewood-Amedex Biotherapeutics Inc. has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $8.00 to the latest recorded price of $7.02, reflecting an intraday change of 0.00%. Daily movements highlight shifts in trading volume (15,891), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, LABT has delivered a -18.90% return over the past month and a -18.90% change in the last 12 months, indicating a Weak trend relative to its broader sector peers.

How to Buy Lakewood-Amedex Biotherapeutics Inc. (LABT)

You can buy and trade LABT on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for LABT and Execute Your Trade

Open the trading page, enter LABT in the search bar, select the amount of LABT you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Lakewood-Amedex Biotherapeutics Inc. (LABT)?

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

Lakewood-Amedex Biotherapeutics Inc. Information

Industry	--
Employees	--
Sector	--
Company Website	https://lakewoodamedex.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Lakewood-Amedex Biotherapeutics Inc.?

The latest trading price for Lakewood-Amedex Biotherapeutics Inc. (Common Stock) is $ 7.02, compared with a previous closing price of $ 7.35. That means the stock has moved 0.00% so far today. Intraday price updates and recent trading activity for LABT can be tracked on the live chart and quote section on this page.

2.Is Lakewood-Amedex Biotherapeutics Inc. stock going up or down?

Looking at recent performances, LABT has returned -18.90% over the past month, -18.90% over the last six months and -18.90% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe Weak price momentum for Lakewood-Amedex Biotherapeutics Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does LABT currently sit relative to its 52-week high and low?

In the most recent 52-week period, Lakewood-Amedex Biotherapeutics Inc. has traded between a low of $ 5.75 and a high of $ 9.82. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether LABT is currently nearer the top or the bottom of its one-year trading band.

4.How is Lakewood-Amedex Biotherapeutics Inc. classified by sector and industry?

Lakewood-Amedex Biotherapeutics Inc. is classified in the -- sector. In practice, this means Lakewood-Amedex Biotherapeutics Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing LABT’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the -- sector could influence Lakewood-Amedex Biotherapeutics Inc.’s performance.

5.Where is Lakewood-Amedex Biotherapeutics Inc. listed and how large is it by market value?

Lakewood-Amedex Biotherapeutics Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 100.25M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Lakewood-Amedex Biotherapeutics Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does LABT's EPS tell investors about its profitability?

Trailing-twelve-month EPS of -- summarises how much profit Lakewood-Amedex Biotherapeutics Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Lakewood-Amedex Biotherapeutics Inc.'s financial performance over time?

To follow Lakewood-Amedex Biotherapeutics Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how LABT is performing and how the market is responding.

8.When is Lakewood-Amedex Biotherapeutics Inc. expected to report earnings?

Lakewood-Amedex Biotherapeutics Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for LABT, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Lakewood-Amedex Biotherapeutics Inc.'s earnings reports?

Lakewood-Amedex Biotherapeutics Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether LABT is meeting, beating or missing expectations.

10.How can I stay informed about Lakewood-Amedex Biotherapeutics Inc.'s results and guidance?

You can stay up to date on Lakewood-Amedex Biotherapeutics Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for LABT on this page helps you see how new information is being reflected in the stock.

11.Does Lakewood-Amedex Biotherapeutics Inc. pay a regular cash dividend to its shareholders?

Lakewood-Amedex Biotherapeutics Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of -- at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor LABT's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for LABT?

Based on the latest earnings data, LABT has a dividend yield of -- and a dividend payout ratio of --. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Lakewood-Amedex Biotherapeutics Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Lakewood-Amedex Biotherapeutics Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Lakewood-Amedex Biotherapeutics Inc.?

Lakewood-Amedex Biotherapeutics Inc. is a publicly traded company in the -- industry within the -- sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is LABT valued in terms of P/E ratio and EPS?

Lakewood-Amedex Biotherapeutics Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of --. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Lakewood-Amedex Biotherapeutics Inc.'s earnings. Comparing LABT's P/E and EPS to those of other -- companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Orion Digital Corp.

ORIO

Definium Therapeutics, Inc.

DFTX

TechnipFMC plc

FTI

Colgate-Palmolive Company

Atlas Critical Minerals Corporation

ATCX

Top Gainers

Browse today's leading gainers in the US stock market

RE/MAX HOLDINGS, INC.

RMAX

Organon & Co.

OGN

Magnachip Semiconductor Corp.

ReposiTrak, Inc.

TRAK

Veradermics, Incorporated

MANE

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

LABT-to-USD Calculator

Amount

LABT

USD

1 LABT = 7.015 USD